The development of new classes of antiretroviral drugs, such as integrase inhibitors and CCR5-antagonistic entry inhibitors, has opened the possibility of considering regimens without NRTIs (Table 1).
TUESDAY, July 8, 2025 (HealthDay News) -- Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback